These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19871508)

  • 1. STUDIES ON THE BIOCHEMICAL, BIOPHYSICAL, AND IMMUNOGENIC PROPERTIES OF JAPANESE B TYPE ENCEPHALITIS VIRUS AND VACCINES.
    Duffy CE; Stanley WM
    J Exp Med; 1945 Nov; 82(6):385-410. PubMed ID: 19871508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE PREPARATION AND PROPERTIES OF INFLUENZA VIRUS VACCINES CONCENTRATED AND PURIFIED BY DIFFERENTIAL CENTRIFUGATION.
    Stanley WM
    J Exp Med; 1945 Feb; 81(2):193-218. PubMed ID: 19871452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INFLUENCE OF pH AND OF CERTAIN OTHER CONDITIONS ON THE STABILITY OF THE INFECTIVITY AND RED CELL AGGLUTINATING ACTIVITY OF INFLUENZA VIRUS.
    Miller GL
    J Exp Med; 1944 Dec; 80(6):507-20. PubMed ID: 19871433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FURTHER STUDIES ON THE PROPERTIES OF PURE VACCINE VIRUS CULTIVATED IN VIVO.
    Noguchi H
    J Exp Med; 1918 Mar; 27(3):425-42. PubMed ID: 19868215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of African horse-sickness virus by betapropiolactone and by pH.
    Parker J
    Arch Virol; 1975; 47(4):357-65. PubMed ID: 237497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen.
    Hunt AR; Cropp CB; Chang GJ
    J Virol Methods; 2001 Sep; 97(1-2):133-49. PubMed ID: 11483224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium.
    Toriniwa H; Komiya T
    Vaccine; 2008 Jul; 26(29-30):3680-9. PubMed ID: 18534722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE NATURE AND CONTROL OF REACTIONS IN BIOLUMINESCENCE : WITH SPECIAL REFERENCE TO THE MECHANISM OF REVERSIBLE AND IRREVERSIBLE INHIBITIONS BY HYDROGEN AND HYDROXYL IONS, TEMPERATURE, PRESSURE, ALCOHOL, URETHANE, AND SULFANILAMIDE IN BACTERIA.
    Johnson FH; Eyring H; Steblay R; Chaplin H; Huber C; Gherardi G
    J Gen Physiol; 1945 May; 28(5):463-537. PubMed ID: 19873433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANTIRABIES ANTIBODY RESPONSE IN MAN TO VACCINE MADE FROM INFECTED SUCKLING-MOUSE BRAINS.
    FUENZALIDA E; PALACIOS R; BORGONO JM
    Bull World Health Organ; 1964; 30(3):431-6. PubMed ID: 14163964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenicity and stability of a Soviet inactivated cultured vaccine against Japanese encephalitis].
    Khanina MK; Bochkova NG; Grachev VP; El'bert LB; Vorob'eva MS; Borsuk EA; Pogodina VV
    Vopr Virusol; 1990; 35(6):478-80. PubMed ID: 2082551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the biochemical, biophysical, and immunogenic properties of Japanese B type encephalitis virus and vaccines.
    DUFFY CE; STANLEY WM
    J Exp Med; 1945; 82():385-410. PubMed ID: 21006185
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on Japanese B encephalitis virus vaccines from tissue culture. XI. Immune mechanism and evaluation of the mouse challenge potency test.
    Singh B; Hammon WM
    Appl Microbiol; 1971 Apr; 21(4):743-8. PubMed ID: 4325023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient method for production of purified inactivated Japanese encephalitis vaccine from mouse brains.
    Gupta RK; Misra CN; Gupta VK; Saxena SN
    Vaccine; 1991 Dec; 9(12):865-7. PubMed ID: 1811372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FURTHER STUDIES ON A LABILE IMMUNOGENIC PARTICULATE SUBSTANCE ISOLATED FROM MYCOBACTERIUM TUBERCULOSIS.
    YOUMANS AS; YOUMANS GP
    J Bacteriol; 1964 Feb; 87(2):278-85. PubMed ID: 14151045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility-pH profile of desipramine hydrochloride in saline phosphate buffer: Enhanced solubility due to drug-buffer aggregates.
    Marković OS; Pešić MP; Shah AV; Serajuddin ATM; Verbić TŽ; Avdeef A
    Eur J Pharm Sci; 2019 May; 133():264-274. PubMed ID: 30914359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FURTHER STUDY ON THE CULTURAL CONDITIONS OF LEPTOSPIRA (SPIROCHAETA) ICTEROHAEMORRHAGIAE.
    Noguchi H
    J Exp Med; 1918 May; 27(5):593-608. PubMed ID: 19868228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-specific, labile, nonvirion antigen in herpesvirus-infected cells.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1970 Mar; 65(3):753-60. PubMed ID: 4317077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE PREPARATION OF HIGHLY PURIFIED PR8 INFLUENZA VIRUS FROM INFECTED MOUSE LUNGS.
    Knight CA
    J Exp Med; 1946 Jan; 83(1):11-24. PubMed ID: 19871513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.